Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sudharshan Eathiraj

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Structure (London, England : 1993)|April 18, 2006
ESCRT complexes assembled and GLUEdSudharshan Eathiraj, David G Lambright
Nature|July 22, 2005
Structural basis of family-wide Rab GTPase recognition by rabenosyn-5Sudharshan Eathiraj, Xiaojing Pan, Christopher Ritacco, et al.
Journal of Molecular Biology|September 30, 2006
Structural basis for Rab11-mediated recruitment of FIP3 to recycling endosomesSudharshan Eathiraj, Ashwini Mishra, Rytis Prekeris, et al.
Nature|July 21, 2006
TBC-domain GAPs for Rab GTPases accelerate GTP hydrolysis by a dual-finger mechanismXiaojing Pan, Sudharshan Eathiraj, Mary Munson, et al.
The Journal of Biological Chemistry|December 21, 2002
Determinants of Rab5 interaction with the N terminus of early endosome antigen 1Eric Merithew, Craig Stone, Sudharshan Eathiraj, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Structural basis for Rab GTPase recognition and endosome tethering by the C2H2 zinc finger of Early Endosomal Autoantigen 1 (EEA1)Ashwini Mishra, Sudharshan Eathiraj, Silvia Corvera, et al.
Anti-Cancer Drugs|February 28, 2017
In-vitro and in-vivo combined effect of ARQ 092, an AKT inhibitor, with ARQ 087, a FGFR inhibitorYi Yu, Terence Hall, Sudharshan Eathiraj, et al.
Plos One|October 16, 2015
Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092Yi Yu, Ronald E Savage, Sudharshan Eathiraj, et al.
The Journal of Biological Chemistry|April 2, 2011
Discovery of a novel mode of protein kinase inhibition characterized by the mechanism of inhibition of human mesenchymal-epithelial transition factor (c-Met) protein autophosphorylation by ARQ 197Sudharshan Eathiraj, Rocio Palma, Erika Volckova, et al.
Plos One|September 15, 2016
Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR DysregulationTerence G Hall, Yi Yu, Sudharshan Eathiraj, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Structure (London, England : 1993)|April 18, 2006
ESCRT complexes assembled and GLUEdSudharshan Eathiraj, David G Lambright
Nature|July 22, 2005
Structural basis of family-wide Rab GTPase recognition by rabenosyn-5Sudharshan Eathiraj, Xiaojing Pan, Christopher Ritacco, et al.
Journal of Molecular Biology|September 30, 2006
Structural basis for Rab11-mediated recruitment of FIP3 to recycling endosomesSudharshan Eathiraj, Ashwini Mishra, Rytis Prekeris, et al.
Nature|July 21, 2006
TBC-domain GAPs for Rab GTPases accelerate GTP hydrolysis by a dual-finger mechanismXiaojing Pan, Sudharshan Eathiraj, Mary Munson, et al.
The Journal of Biological Chemistry|December 21, 2002
Determinants of Rab5 interaction with the N terminus of early endosome antigen 1Eric Merithew, Craig Stone, Sudharshan Eathiraj, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Structural basis for Rab GTPase recognition and endosome tethering by the C2H2 zinc finger of Early Endosomal Autoantigen 1 (EEA1)Ashwini Mishra, Sudharshan Eathiraj, Silvia Corvera, et al.
Anti-Cancer Drugs|February 28, 2017
In-vitro and in-vivo combined effect of ARQ 092, an AKT inhibitor, with ARQ 087, a FGFR inhibitorYi Yu, Terence Hall, Sudharshan Eathiraj, et al.
Plos One|October 16, 2015
Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092Yi Yu, Ronald E Savage, Sudharshan Eathiraj, et al.
The Journal of Biological Chemistry|April 2, 2011
Discovery of a novel mode of protein kinase inhibition characterized by the mechanism of inhibition of human mesenchymal-epithelial transition factor (c-Met) protein autophosphorylation by ARQ 197Sudharshan Eathiraj, Rocio Palma, Erika Volckova, et al.
Plos One|September 15, 2016
Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR DysregulationTerence G Hall, Yi Yu, Sudharshan Eathiraj, et al.
Pageof 2